+15% CAGR & COVID-19 Impact on Difluprednate Market Can See 451 Million by 2027 Major Novartis, Ajanta Pharma, Sun Pharmaceutical, General Pharmaceuticals, Orchidia
Over the next five years the Difluprednate market will register a 15.5% CAGR in terms of revenue, the global market size will reach US$ 451 million by 2026
View full press release